Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
| ▸ | VNN1 | O95497 | 13/20 | 0.50 |
| ▸ | ECE1 | P42892 | 3/20 | 0.36 |
| ▸ | AURKA | O14965 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pantothenic Acid SCHEMBL14126323 | 1.00 | PTGS1 (0.52) | PTGS1KCNH2VNN1ECE1AURKA | |
| SCHEMBL7763866 | 0.92 | PTGS1 (0.52) | PTGS1KCNH2VNN1AURKA | |
| SCHEMBL4851665 | 0.88 | PTGS1 (0.71) | PTGS1KCNH2VNN1AURKA | |
| SCHEMBL28165293 | 0.87 | PTGS1 (0.56) | PTGS1KCNH2VNN1AURKA | |
| Pantothenic Acid, Racemic SCHEMBL5437 | 0.87 | PTGS1 (0.67) | PTGS1KCNH2VNN1ECE1 | |
| Pantothenic Acid SCHEMBL21547 | 0.87 | PTGS1 (0.67) | PTGS1KCNH2VNN1ECE1 | |
| Pantothenic Acid SCHEMBL29872649 | 0.87 | PTGS1 (0.67) | PTGS1KCNH2VNN1ECE1 | |
| Pantothenic Acid SCHEMBL7016631 | 0.87 | PTGS1 (0.67) | PTGS1KCNH2VNN1ECE1 | |
| Pantothenic Acid, Racemic SCHEMBL21114380 | 0.87 | PTGS1 (0.67) | PTGS1KCNH2VNN1ECE1 | |
| Pantothenic Acid SCHEMBL14126322 | 0.87 | PTGS1 (0.67) | PTGS1KCNH2VNN1ECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7964234-B2 | High mineral content dietary supplement | NEWAYS, INC. (US) | 2011-06-21 | — | — | US | disclosed |
| EP-1322751-A2 | GLUTARYL CEPHALOSPORIN AMIDASE FROM PSEUDOMONAS DIMINUTA BS-203 | Bristol-Myers Squibb Company (US) | 2003-07-02 | — | — | EP | disclosed |
| EP-1091738-A4 | BICYCLIC sPLA 2 INHIBITORS | LILLY CO ELI (US) | 2003-03-05 | — | — | EP | disclosed |
| WO-2002024879-A2 | GLUTARYL CEPHALOSPORIN AMIDASE FROM PSEUDOMONAS DIMINUTA BS-203 | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-03-28 | — | — | WO | disclosed |
| EP-1091738-A1 | BICYCLIC sPLA 2 INHIBITORS | ELI LILLY AND COMPANY (US) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000000201-A1 | BICYCLIC sPLA2 INHIBITORS | ELI LILLY AND COMPANY (US) | 2000-01-06 | — | — | WO | disclosed |